Published in Urologiia on May 19, 2006
The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment. Proc Natl Acad Sci U S A (1999) 0.95
Dysfunctionality of a tobacco mosaic virus movement protein mutant mimicking threonine 104 phosphorylation. J Gen Virol (2003) 0.93
Scale of Quality of Life of Care-Givers (SQLC). J Neurol (1998) 0.91
In situ spatial organization of Potato virus A coat protein subunits as assessed by tritium bombardment. J Virol (2001) 0.89
The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles. J Neurol Neurosurg Psychiatry (2004) 0.87
[The influence of partial androgen deficiency of aging men (PADAM) on the impulse regime of incretion of several hormones and mitotic activity]. Tsitologiia (2006) 0.82
[Changes in the expression of receptors of steroid hormones in the development of partial androgen deficiency of aging men (PADAM)]. Tsitologiia (2005) 0.80
[Disordered regions in C-domain structure of influenza virus M1 protein]. Mol Biol (Mosk) (2011) 0.80
A model for the study of the mechanism of a low pH-induced interaction of the virus fusion proteins and cell membranes. Biosci Rep (1991) 0.80
Influenza A virus M1 protein structure probed by in situ limited proteolysis with bromelain. Protein Pept Lett (2008) 0.79
[An approach the quantitative determination of the area of glycoprotein spikes at the surface of enveloped viruses]. Mol Biol (Mosk) (2009) 0.79
[Surgical treatment of ectopic ureter in females]. Zentralbl Gynakol (1983) 0.79
[A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia]. Urol Nefrol (Mosk) (1995) 0.79
[Experience in the use of doxazosin in patients with benign hyperplasia of the prostate]. Urol Nefrol (Mosk) (1998) 0.78
[Localization of the influenza virus M1 matrix protein in the virion]. Mol Biol (Mosk) (2000) 0.77
[The role of the MAO-B inhibitor razagiline in the treatment of Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.76
[Prostaglandin E1 in the diagnosis and therapy of erectile disorders]. Urol Nefrol (Mosk) (1995) 0.76
[Allergic inflammation as one of the factors of pathogenesis of overactive urinary bladder]. Urologiia (2007) 0.75
[Nocturnal motor symptoms of Parkinson's disease and their treatment with the three-component drug levodopa/carbidopa/entacapone]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.75
[The use of pronoran (piribedil) in Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.75
[Changes in the laboratory indices in peritonitis]. Lab Delo (1982) 0.75
[The temporal characteristics of "winter" paradoxical sleep in the hibernating suslik Citellus major]. Zh Evol Biokhim Fiziol (1995) 0.75
[Changes in certain indicators of hemodynamics, acid-base equilibrium and electrolytes in burns]. Sov Med (1976) 0.75
[The treatment of Parkinson disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.75
ATP as effector of inorganic pyrophosphatase of Escherichia coli. Identification of the binding site for ATP. Biochemistry (Mosc) (2007) 0.75
[Local indentation of the sclera by means of the Achilles tendon in the treatment of retinal detachment]. Oftalmol Zh (1975) 0.75
Paradoxical sleep considerably contributes to the night decrease in brain temperature in hibernating mammals in summer. Dokl Biol Sci (2001) 0.75
[The effect of amino acids and polypeptides on the biomass autolysis process of Saccharomyces cerevisiae]. Prikl Biokhim Mikrobiol (1994) 0.75
[Generation of nitric oxide by peripheral blood leukocytes and platelets in healthy people and in patient with thermal trauma]. Fiziol Cheloveka (2003) 0.75
[The serotonin content and phagocytic activity of leukocytes in radiotherapy]. Med Radiol (Mosk) (1967) 0.75
[Use of sodium hypochlorite in the multimodal treatment of alcoholic delirium as a complication of acute poisoning]. Anesteziol Reanimatol (1999) 0.75
[A method for the self-assessment of social adaptation in parkinsonism patients]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.75
[The endogenic intoxication during the early post-operational period in patients with combined intraabdominal injury and massive loss of blood]. Klin Lab Diagn (2012) 0.75
[Effectiveness of vasoactive preparations in patients with circulatory encephalopathy]. Klin Med (Mosk) (1988) 0.75
[Effect of gastroenterological disorders on the quality of life in patients with Parkinson's disease]. Eksp Klin Gastroenterol (2009) 0.75
[Production and study of anthrax antigen. I. Nutrient medium for production of native anthrax protective antigen]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[Impulsive-compulsive syndrome in Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2013) 0.75
[Electrostimulation of a subthalamic nuclear area in Parkinson's disease]. Zh Vopr Neirokhir Im N N Burdenko (2006) 0.75
[Preparation and study of the anthrax protective antigen. II. Development of test preparations for the assessment of the quality of anthrax chemical vaccines and of the antigens obtained at various stages of its preparation]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[Neurotransplantation in the treatment of Parkinson disease: follow-up]. Zh Vopr Neirokhir Im N N Burdenko (2002) 0.75
[The efficacy of the Umex treatment of parkinsonism patients in the initial stage of the disease]. Ter Arkh (1995) 0.75
[Study of serum levels of homocystein, lipids and their peroxidation products in patients with coronary heart disease]. Klin Med (Mosk) (2005) 0.75
[The properties of the epidemic influenza viruses A and B strains circulating in Russia in the 2004-2005 epidemic season]. Vopr Virusol (2007) 0.75
[Dyscirculatory encephalopathy]. Sov Med (1988) 0.75
[Correlation between the indicators of blood coagulation and various biogenic amines in gastroduodenal hemorrhage]. Lab Delo (1986) 0.75
[Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain]. Zh Nevropatol Psikhiatr Im S S Korsakova (1985) 0.75
[Internal epidemic influenza virus proteins: isolation and investigation]. Vopr Virusol (2006) 0.75
[Dose-dependent effects of intracisternally administered insulin on rat's behavior and glucose level]. Ross Fiziol Zh Im I M Sechenova (2007) 0.75
[Sinusotrabeculectomy]. Oftalmol Zh (1971) 0.75
[The use of a complex preparation of alpha-interferon and first-phase immune-response cytokines--leukinferon]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Revolutionary activities of Simbirsk physicians during the 1st Russian Revolution]. Sov Zdravookhr (1985) 0.75
[Laboratory changes in exo- and endotoxemia in toxicohypoxic encephalopathy occurring with acute poisoning by psychopharmacological agents]. Anesteziol Reanimatol (2006) 0.75
Experimental proof of optimality of interfacing of chlorosome BChl c and membrane BChl a subantennae in superantenna of photosynthetic green bacteria from the oscillochloridaceae family. Dokl Biochem Biophys (2012) 0.75
[Enzymatic electrophoresis in eye diseases]. Oftalmol Zh (1980) 0.75
[Endogenous intoxication parameters in the assessment of a risk for pneumonias in acute azaleptin intoxications]. Klin Lab Diagn (2007) 0.75
[Differential diagnosis of parkinsonism]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.75
[Amino acid and peptide derivatives of the tylosin family of macrolide antibiotics modified at the aldehyde group]. Bioorg Khim (2010) 0.75
[A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2004) 0.75
[Role of dopamine receptor agonists in the treatment of depression in patients with Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2009) 0.75
[Stalevo (levodopa/carbidopa/entacapon)--a new generation drug in the treatment of Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.75
[The clinical-pharmacoeconomic study of efficacy of stalevo in the treatment of Parkinson's disease with motor fluctuations]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.75
[Integral assessment of endogenous intoxication in patients with purulent mediastinitis]. Klin Lab Diagn (2008) 0.75
[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.75
[Camptocormia in patients with Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2013) 0.75
[Peptide derivatives of tylosin-related macrolides]. Bioorg Khim (2007) 0.75
[Differences in the spatial structure of an envelope protein from tobacco mosaic virus and its mutant, detected by tritium planigraphy]. Mol Biol (Mosk) (2001) 0.75
[Role of changes in blood serotonin and histamine concentrations in the pathogenesis of pneumonia in burns]. Ter Arkh (1984) 0.75
[An imbalance in the natural cation ratio in the water as a factor affecting the synthesis of lipids and fatty acids in fish eggs]. Ontogenez (2000) 0.75
[Differences in spatial structures of the influenza virus M1 protein in crystal, solution and virion]. Bioorg Khim (2012) 0.75
[Evaluation of endogenous intoxication from average molecular weight peptides during emergency situations]. Klin Lab Diagn (2009) 0.75
[Time course of toxic hypoxic encephalopathy during combined therapy including hyperbaric oxygenation]. Anesteziol Reanimatol (2002) 0.75
[The effect of amantadine sulfate on cognitive disorders in patients with Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2010) 0.75
[Use of serotonin adipinate in combined therapy of hemodynamic disorders in acute poisoning by psychopharmacological preparations]. Anesteziol Reanimatol (1999) 0.75
[Enzymatic profile of autolysing Saccharomyces yeasts]. Prikl Biokhim Mikrobiol (1993) 0.75
[Levodopa medications in the treatment of Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.75
[Changes in some biochemical indicators in severe combined injury]. Sov Med (1976) 0.75
[Biochemical criteria for assessing the severity of the status of wounded patients with gunshot damages to the chest and abdomen]. Vestn Khir Im I I Grek (1998) 0.75
[Carbon assimilation from a NaHCO3 nutrient medium by an STI-1 strain culture]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[Preparative isolation of basic structural proteins of the influenza virus]. Mol Gen Mikrobiol Virusol (1992) 0.75
[Immunological aspects of the early application of extracorporeal hemocorrection techniques in the complex therapy of purulent mediastinitis]. Anesteziol Reanimatol (2008) 0.75
[Use of neurotransplantation in the treatment of Parkinson's disease]. Vestn Ross Akad Med Nauk (1996) 0.75
[Thermoregulation and wakefulness-sleep cycle in the ground squirrel subjected changes in the temperature regime of the thermosensitive region of the frontal hypothalamus]. Zh Evol Biokhim Fiziol (2000) 0.75
[The treatment of patients with toxic encephalopathy caused by using surrogate psychoactive manganese-containing compounds]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.75
[Hydrolyzing ability of yeast proteases in relation to protein substrates]. Prikl Biokhim Mikrobiol (1996) 0.75
[Mechanism of the effect of immobilized noradrenaline on the contact phase of blood coagulation]. Vopr Med Khim (1979) 0.75
[Biogenic amines (serotonin and histamine) in Rendu-Osler disease]. Ter Arkh (1975) 0.75
[Effect of phytohemmaglutinin and hydrocortisone on the glucocorticoid receptor level and DNA synthesis in human peripheral blood lymphocytes]. Probl Gematol Pereliv Krovi (1980) 0.75
[Hyperbaric oxygenation as a method of intensive therapy in acute exogenous poisoning]. Anesteziol Reanimatol (1999) 0.75
[The dynamic of biochemical stress reaction inductors in various tactics for surgical treatment of patients with a combined trauma of cranium and lower limbs ]. Vopr Med Khim (2000) 0.75
[Indices of oxidation-reduction processes in severe forms of late pregnancy toxicosis]. Akush Ginekol (Mosk) (1978) 0.75
[Significance of serotonin in the pathogenesis of diabetic retinopathy and central chorioretinal dystrophy]. Vestn Oftalmol (2002) 0.75
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.75
[Correction of volemic disorders in peptic ulcer hemorrhage in middle-aged and elderly patients]. Khirurgiia (Mosk) (1976) 0.75
[Changes in the indices of blast transformation reactions of the peripheral blood lymphocytes and in the level of 11-hydroxycorticosteroids, serotonin and histamine in acute myocardial infarct]. Klin Med (Mosk) (1982) 0.75
[Thrombocytopathies and their role in the development of hemorrhagic syndrome in vascular diseases of the fundus oculi]. Vestn Oftalmol (2001) 0.75
[Tolcapone treatment of late stages of Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.75
[Comparison of the effectiveness of treatment with diverse doses of cinnarizine of patients with circulatory encephalopathy]. Klin Med (Mosk) (1989) 0.75
[Clinical study of the cerebrovascular action of pentoxifylline]. Zh Nevropatol Psikhiatr Im S S Korsakova (1982) 0.75
[Histamine dynamics of blood and basophils in patients with closed chest injuries]. Lab Delo (1988) 0.75
[Hyperbaric oxygenation in traumatic tissue edema]. Sov Med (1983) 0.75